GALLI, MARCO
 Distribuzione geografica
Continente #
NA - Nord America 247
AS - Asia 94
EU - Europa 76
SA - Sud America 25
AF - Africa 5
Totale 447
Nazione #
US - Stati Uniti d'America 241
SG - Singapore 46
BR - Brasile 24
IT - Italia 22
SE - Svezia 19
CN - Cina 17
HK - Hong Kong 17
RU - Federazione Russa 15
DE - Germania 6
VN - Vietnam 6
GB - Regno Unito 4
CA - Canada 3
IN - India 3
AT - Austria 2
FI - Finlandia 2
ID - Indonesia 2
PL - Polonia 2
AR - Argentina 1
BD - Bangladesh 1
CI - Costa d'Avorio 1
DZ - Algeria 1
ES - Italia 1
FR - Francia 1
JP - Giappone 1
KE - Kenya 1
LT - Lituania 1
MX - Messico 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PK - Pakistan 1
RS - Serbia 1
TN - Tunisia 1
Totale 447
Città #
Ashburn 38
Fairfield 38
Singapore 24
Woodbridge 18
Hong Kong 17
Chandler 16
Houston 14
Seattle 13
Nyköping 12
Beijing 9
Wilmington 9
Cambridge 8
Los Angeles 7
Munich 5
Ann Arbor 4
Dallas 4
Dearborn 4
Falls Church 4
Rome 4
Ho Chi Minh City 3
Roxbury 3
Santa Clara 3
Torino 3
Brooklyn 2
Helsinki 2
Jakarta 2
Lawrence 2
Montreal 2
New York 2
Orem 2
Ribeirão Preto 2
São Paulo 2
Vienna 2
Abidjan 1
Ahmedabad 1
Algiers 1
Atlanta 1
Bari 1
Belgrade 1
Belo Horizonte 1
Boardman 1
Brasília 1
Brescia 1
Buffalo 1
Camaçari 1
Caruaru 1
Chennai 1
Chicago 1
Concórdia 1
Delhi 1
Denver 1
Des Moines 1
Extrema 1
Fortaleza 1
Frankfurt am Main 1
Garín 1
Gateshead 1
Guangzhou 1
Hebei 1
Honolulu 1
Inglewood 1
Islamabad 1
Itamaraju 1
Itanhaém 1
Jacksonville 1
Kilburn 1
Managua 1
Manhumirim 1
Marshall 1
Mexico City 1
Milan 1
Modugno 1
Mount Laurel 1
Nairobi 1
North Bergen 1
Norwalk 1
Olinda 1
Panama City 1
Parauapebas 1
Paulínia 1
Pelotas 1
Phoenix 1
Poplar 1
Quận Bình Thạnh 1
Reggio Nell'emilia 1
Ribeirão Branco 1
Rio Grande 1
Rio de Janeiro 1
San Diego 1
San Jose 1
Santa Maria de Jetibá 1
Stockholm 1
Suleja 1
São José 1
Thái Bình 1
Thái Nguyên 1
Tianjin 1
Tokyo 1
Toronto 1
Tunis 1
Totale 347
Nome #
Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project 154
Carfilzomib-Lenalidomide-Dexamethasone (KRd) Induction-Autologous Transplant (ASCT)-Krd Consolidation Vs KRd 12 Cycles Vs Carfilzomib-Cyclophosphamide-Dexamethasone (KCd) Induction-ASCT-KCd Consolidation: Analysis of the Randomized Forte Trial in Newly Diagnosed Multiple Myeloma (NDMM) 126
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 73
Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study 73
Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study 39
Totale 465
Categoria #
all - tutte 2.237
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.237


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202128 0 0 0 0 0 0 6 9 0 6 1 6
2021/202247 6 8 0 0 2 7 2 3 3 4 4 8
2022/202331 4 9 3 1 1 4 0 5 3 0 0 1
2023/202427 3 7 1 4 2 5 1 1 0 1 0 2
2024/2025108 4 3 8 0 6 20 10 8 3 3 17 26
2025/2026124 40 12 14 23 26 9 0 0 0 0 0 0
Totale 465